| 发明名称 | Forms of rifaximin and uses thereof | ||
| 摘要 | The present invention relates to Rifaximin amorphous forms, to their use in medicinal preparations and to therapeutic methods using them. | ||
| 申请公布号 | US9359357(B2) | 申请公布日期 | 2016.06.07 |
| 申请号 | US201414580458 | 申请日期 | 2014.12.23 |
| 申请人 | Salix Pharmaceuticals, Ltd.;Alfa Wassermann S.P.A. | 发明人 | Gushurst Karen S.;Yang Donglai;Bevill Melanie Janelle;Schultheiss Nathan Carl;Viscomi Giuseppe Claudio |
| 分类号 | C07D471/22;C07D498/16;C07D498/18 | 主分类号 | C07D471/22 |
| 代理机构 | McCarter & English, LLP | 代理人 | McCarter & English, LLP ;Sparks Jonathan M.;DeGrazia Michael J. |
| 主权项 | 1. An amorphous form of rifaximin, wherein the amorphous form exhibits an X-ray powder diffraction pattern having characteristic peaks expressed in degrees 2θ (+/−0.20 degree θ) at 7.3, 11.3-17.8, and 15.8 degrees 2θ. | ||
| 地址 | Bridgewater NJ US | ||